Transaction · 0001273351-26-000006
DNTHDianthus Therapeutics, Inc. DE
Carr Edward
CARR EDWARD, CAO, reported a transaction classified as exercise at Dianthus Therapeutics, Inc. DE involving 20000.000000 shares for an estimated $357600.00. Reported holdings after the transaction were 20000.000000 shares. The stored filing text includes a detected 10b5-1 reference.
exerciseSEC transaction code MCAO
- Trade date
- Sep 17, 2026
- Filing date
- Sep 18, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
DNTH price since this filing
Daily closing prices, with the filing date and available return windowsDNTH · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +19.3%1w ago +6.7%1d ago +5.9%
Returns since7d -8.5%30d -25.5%90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001273351-26-000006 Common Stock
- Transaction date
- Sep 17, 2026 Filed Sep 18, 2026, 08:36 PM · 1d delay
- Shares
- 20,000 sh $17.88 per share
- Estimated value
- $357k Computed from shares × price
- Holdings after
- 20,000 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase 10b5-1 Detected
Filing-only score
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
Neutral filing signal
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
CHIEF ACCOUNTING OFFICER
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026.
- F2
The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.98 to $100.97, inclusive. The Reporting Person undertakes to provide to t…
- F3
The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.99 to $101.95, inclusive. The Reporting Person undertakes to provide to…
- F4
The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.99 to $102.95, inclusive. The Reporting Person undertakes to provide to…
- F5
The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.05 to $103.38, inclusive. The Reporting Person undertakes to provide to…
- F6
The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $104.17 to $104.63, inclusive. The Reporting Person undertakes to provide to…
- F7
The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the I…
Related transactions
Same SEC filing0 other transactions
Recent company activity
DNTH0 recent txs